Physician profile
Jyoti Krishna
NPI 1508862400
$1,033.78
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Sleep Medicine (Pediatrics) provider received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $216 · 2021: $100 · 2024: $15.52 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $150 · Food and Beverage: $65.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150.00 |
| Food and Beverage | $65.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $215.99 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $198.82 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $169.85 | 2019-2021 | |
| Abbvie INC. | $115.91 | 2019-2021 | |
| Sobi, INC | $106.07 | 2019-2020 | |
| Glaxosmithkline, LLC. | $63.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $35.19 | 2019-2020 | |
| Electromed, INC. | $22.50 | 2019 | |
| Digestive Care, INC. | $16.86 | 2025 | Pertzye |
| Chiesi USA, INC. | $16.62 | 2020 | |
| Fisher & Paykel Healthcare INC | $16.45 | 2025 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $15.52 | 2024 | Lumryz |
| Genzyme Corporation | $14.62 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.00 | 2019 | |
| Mylan Specialty L.P. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyoti Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.